Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ati Teknoloji is a Turkish biotechnology company specializing in regenerative medicine and cellular therapy production. Based in Trabzon, the company operates a state-of-the-art GMP-certified facility dedicated to the processing, production, and cryopreservation of various stem cell types. Their core services include cord blood banking under the brand Aticord and the manufacturing of mesenchymal stem cells for clinical applications in orthopedics and hematology. As one of the first private GMP-compliant stem cell centers in Turkey, Ati Teknoloji provides critical infrastructure for both commercial healthcare and academic research. The company is a key player in the regional life sciences ecosystem, supporting the development of advanced therapy medicinal products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ati Teknoloji.